Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
Features
A Philadelphia judge recently ruled that a federal law governing the liability of pharmaceutical companies for drug vaccines pre-empts state tort claims of design defect and failure to warn in the product liability case of an 11-year-old boy who has autism.
Features
In-depth analysis of recent rulings.
Everything contained in this issue, in an easy-to-read format.
What do FEMA trailers, peanut butter, Viagra, pet food, tires, implantable defibrillators, Agent Orange and iPods have in common? A really weird dream? Maybe. Mass product liability litigation? Ding!
Features
What building modifications trigger an obligation to comply with the accessibility requirements of the Americans with Disabilities Act (ADA)? The Second Circuit addressed that question in <i>Roberts v. Royal Atlantic Corp.</i> and reached a number of important conclusions.
Features
When you file a suit on behalf of an out-of-state plaintiff, the state in which you file may have a borrowing statute. This type of statute usually prevents forum shopping by requiring the out-of-state plaintiff to file his case in the forum state within the statute of limitations permitted by his home state. Following is an analysis of this situation.
Features
One of the great dramas playing in the theater of American jurisprudence is the epic struggle that roils pharmaceutical labeling. Simply put, the labeling issue confronting the Supreme Court this term is: Who decides the adequacy of drug labeling ' the FDA or a jury of plaintiff's peers?
Features
In Part One of this article, the authors covered ethical issues relating to e-mail. In Part Two below, they discuss ethical issues related to e-discovery and social networking and blogs.
Leadership competencies are critical for lawyers on many fronts. While leadership is not taught in law school, many firms have begun to implement formal leadership development programs. Here's how to do it.
Many partner disputes are resolved informally through discussions with firm management. However, many firms do not have a formal internal grievance procedure for partnership-related matters. What happens when the dispute cannot be amicably resolved? Is litigation the sole solution?
